Tatva Chintan Pharma Chem Limited

₹1,624As of Sun 8 Nov 2026, 12:00 UTC
NSE:TATVAMaterials
Country India
PE (Fwd) •••
TSR 5Y CAGR (6.02%)
Div yield 0.12%
ROE 8.02%
Specialty Chemicals
Beta (5Y) 0.32
PE TTM 60.39
TSR TTM 14.35%
Mkt cap ₹38.00B
ROIC 7.13%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹1,606
(1.15%)
(54.79%)
Hold 9|4|12|1|5
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
18.23
20.03
20.11
22.24
27.66%
26.90%
21.07%
27.61%
Revenue₹B
3.404
3.488
3.488
3.654
7.64%
7.55%
3.85%
6.42%
Peers (US$398.5M)
Cap (US$)
PE
395.2M
35.93x
398.9M
3,051x
Capital
TTM
5Y
10Y
Leveragex
0.950
(0.346)
(0.358)
EBIT/Intx
1.805
0.098
0.107
Own earn%
(18.04)
(101.37)
(70.82)
Sh yield%
20.71
31.34
34.40
Owners
Insiders/Inst%
13.68
56.46
Short interest%
5.58
SBC / revenue%
1.73
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
21–28
$1 testx
0.3
Incr. ROIC%
5